Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antioxidant di- and triacetic acid derivatives: preparation and use described by L'Oreal

May 11, 1999

Structural Bioinformatics develops antagonists of BcL-2 gene product

May 10, 1999

Licensing opportunity from NIH: recombinant antitumor RNases

May 10, 1999

BE-55051: novel antitumor substance produced by Streptomyces

May 7, 1999

Second-generation SERM advances through the Lilly pipeline

May 7, 1999

Clinical trials of SuperGen's RFS-2000 expanded to Europe

May 7, 1999

NCI funds phase II trials of Sugen's lead angiogenesis inhibitor

May 7, 1999

New phase I/II study evaluates G-3139 + docetaxel

May 6, 1999

New Incyte invention provides RBTNH and related products, and use thereof

May 6, 1999

Inhibitors of ras-transformed cell growth under study at Yuhan

May 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.